Status:
TERMINATED
Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Background: Some people who have had COVID-19 experience changes in the eye. Sometimes these changes are subtle and may not affect vision. Researchers want to learn how many people experience these e...
Detailed Description
Study Description: The objective of this study is to understand the rate and extent of ocular involvement in COVID-19 patients and whether SARS-COV-2 can be detected in ocular fluids or tissue in con...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 18 or older.
- History of positive PCR or positive IgG for SARS-CoV-2 cases and if known history of COVID-19 infection, at least 30 days passed since a positive PCR for SARS-COV-2 and have been asymptomatic for at least 10 days.
- Willing to undergo study required testing and blood draw.
- Willing to have blood samples stored for future research.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Current symptoms consistent with COVID-19 infection.
- Any condition or event that, in the PI s opinion, may substantially increase the risk associated with study participation or compromise the study's scientific objectives. Conditions that exclude a subject are considered to be unlikely, but an example would include having an acute respiratory infection or recent exposure that would make it unsafe to perform study procedures or obtain blood samples.
- Pregnant and decisionally impaired individuals will be excluded from participation.
Exclusion
Key Trial Info
Start Date :
February 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 28 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04665752
Start Date
February 2 2021
End Date
January 28 2022
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892